Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunogenicity and Safety of Different rMenB Plus MenACWY Formulations in Adolescents
This study has been completed.
Study NCT01210885   Information provided by Novartis

First Received on September 27, 2010.   Last Updated on October 21, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Meningococcal Disease
Meningococcal Meningitis
Additional conditions recognized in this trial
Meningitis
Meningitis, Meningococcal
Meningococcal Infections
More general conditions related to this trial
Bacterial Infections
Central Nervous System Bacterial Infections
Central Nervous System Diseases
Central Nervous System Infections
Gram-Negative Bacterial Infections
Meningitis, Bacterial
Neisseriaceae Infections
Nervous System Diseases
Interventions listed in this trial
Meningococcal Vaccine
Sponsors listed in this trial
Novartis Vaccines


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services